14.50CAD-0.68%Mkt Cap: 119.66M $P/E: 18.591d ago
BioSyent Inc., together with its subsidiaries, acquires or licenses, develops, and sells pharmaceutical and other healthcare products in Canada and internationally. Its products include FeraMAX Pd Therapeutic 150 for the…
Industry Peers
Drug Manufacturers - Specialty & GenericIndicators:|
Key Statistics
Company
Market Cap119.66M $
Enterprise Value117.50M $
Revenue (TTM)33.49M $
Gross Profit24.01M $
Net Income (TTM)6.56M $
Revenue/Share2.969 USD
Last Price14.50 CAD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees—
CountryCA
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ISIN—
Valuation
P/E (Trailing)18.59
P/E (Forward)25.89
PEG—
EV/EBITDA12.86
EV/Revenue3.51
P/S3.57
P/B3.68
EPS (TTM)0.78
EPS (Forward)0.56
52W Range
10.6575% of range15.80
52W High15.80 CAD
52W Low10.65 CAD
Profitability
Gross Margin76.57%
Oper. Margin24.61%
EBITDA Margin27.29%
Profit Margin20.93%
ROE21.73%
ROA18.23%
Growth
Revenue Growth26.70%
Earnings Growth0.50%
Cash Flow & Leverage
Operating CF6.56M $
CapEx (TTM)283.88K $
FCF Margin13.16%
FCF Yield3.68%
Net Debt-4.12M $
Net Debt/EBITDA-0.45
Balance Sheet
Debt/Equity0.02
Current Ratio1.89
Quick Ratio1.11
Book Value/Sh3.935 CAD
Cash/Share0.9530 CAD
Dividends
Fwd Div Rate0.2200 CAD
Trail. Div Rate0.2050 CAD
Div. Yield1.51%
5Y Avg Yield—
Payout Ratio26.15%
Ex-Div DateMay 29, 2026
Pay DateJun 15, 2026
Analyst Consensus
Rating—
Target (Mean)18.00 CAD
Upside (mean)+24.1%
Target Range18.00 CAD – 18.00 CAD
# Analysts1
Ownership
Shares Out.11.33M
Float9.25M
Insiders34.86%
Institutions4.00%
Short Interest
Short Ratio0.2d
Short % Out.0.02%
Shares Short684
Short (prev mo.)655
Technical
SMA 5014.20 (+2.1%)
SMA 20013.41 (+8.1%)
Beta0.63
S&P 52W Chg20.25%
Avg Vol (30d)9.96K
Avg Vol (10d)4.84K
Technical Indicators
RSI (14)54.8
MACD0.1312
MACD Signal0.1152
MACD Hist.+0.0160
BB Upper14.95 CAD
BB Middle14.36 CAD
BB Lower13.78 CAD
BB Width8.17%
ATR (14)0.1894 CAD
Vol Ratio (20d)0.51x